Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Platt’s BlueCrest Raising Capital for Feeder Fund

Michael Platt‘s BlueCrest Capital Management is one of Europe’s largest hedge funds, and it is about to get bigger. According to Reuters, the firm “is looking to raise more than £150 million ($235 million) for a new listed feeder fund into its computer-driven BlueTrend fund.” It had rough

BlueTrend is headed by Leda Braga, the firm’s head of systematic trading.  It was one of the few funds to profit in 2008, gaining just under 43%. As of the end of the fourth quarter, the BlueTrend program had assets under management of $13.6 billion, while BlueCrest Capital Management had assets under management of approximately $29 billion.

Last year, BlueTrend made just 0.10% – not bad at all considering the average lost roughly 5% last year. “The main BlueTrend fund has been shut to new investors for the past 18 months,” according to Reuters. “In 2010, BlueCrest shut a EU-regulated Ucits version of BlueTrend due to its inability to replicate sufficiently the performance of the main offshore fund.” The firm is able to launch the new feeder fund after creating extra capacity by enhancing its main fund’s computer systems.

BlueCrest was founded by Michael Platt and William Reeves in 2000. Its headquarters are in Guernsey, but the bulk of its traders are in London and Geneva, a move made in 2010 amidst uncertainty over economic stability in the UK.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!